Regulation of the Pharmaceuticals Market in EU Countries
Download as PDF
DOI: 10.25236/icebmi.2020.031
Author(s)
Maya F. Krichevskaya
Corresponding Author
Maya F. Krichevskaya
Abstract
This article discusses the characteristics of pharmaceutical market regulation in the member states of the European Union. The author considers the correlation of EU regulation with national standards and reveals the characteristic features of regulation in Germany and France. The author focuses on the authorization procedure to place medicinal products for human use on the market of Member States, regulation of price of medicinal products and parallel importation issues. The article concludes that the EU pharmaceutical market is regulated at the EU and national levels. Despite the harmonization and unification of legislation in the EU member states, there is difference in legal regulation, which hinders the development of the common market.
Keywords
EU Pharmaceutical Market, Marketing Authorization, Regulation of Price, Parallel Import